Today's <I>MDD</I> food for med-tech thought

"I think we'll ultimately be approved. It's just a matter of time and finding the right path."

— John McCutcheon, president/CEO of Emphasys, discussing an FDA advisory committee vote against approvability of his company's Zephyr device, "Emphysema device comes up short with iffy efficacy data," pp. 1, 6.